U.S. Specialty Stores Stock News

On 28 May 2026, Broadridge Financial Solutions announced an extension of its relationship with Kyndryl to modernize core platforms using Kyndryl Bridge, the Kyndryl Agentic AI Framework and quantum-safe capabilities, including upgrades to data centers, network architecture and mainframe environments to bolster resiliency, scalability and cryptographic protection. This deeper collaboration highlights Kyndryl’s role as a key infrastructure and AI partner to major financial institutions,...

Clean Harbors stock update after recent performance Clean Harbors (CLH) has recently drawn attention after a mixed stretch in its share performance, with the stock down slightly over the past week, month, and past 3 months, while longer term returns remain positive. See our latest analysis for Clean Harbors. At a share price of $281.0, Clean Harbors has recently given back some ground, with short term share price returns weaker even as the 1-year total shareholder return of 24.46% and 5-year...

Recent commentary from Goldman Sachs put Masco (MAS) back in focus, as analysts highlighted the company’s operational expertise, brand strength, margin expansion opportunities, and management’s push on product development and tighter cost controls. See our latest analysis for Masco. Masco’s share price has had a mixed few months, with the stock down 3.17% over 30 days but still up 7.00% year to date. The 1-year total shareholder return of 14.58% and 3-year total shareholder return of 42.93%...

Pitney Bowes recently opened a 75,000-square-foot, highly automated Presort Services operating center in Phoenix, AZ, expanding regional capacity with eight high-speed MLOCR sorters, a connected conveyor system, and 17 dock doors staffed by more than 100 employees across three shifts. This new facility, capable of handling nearly 2.00 billion mailpieces annually within a network that processed over 15.00 billion pieces in fiscal 2025, underlines how Presort Services remains central to Pitney...

Keurig Dr Pepper (KDP) recently reaffirmed its quarterly dividend at US$0.23 per share, payable on July 10, 2026, following Q1 revenue growth of over 9% and updated full year expectations. See our latest analysis for Keurig Dr Pepper. The reaffirmed dividend and Q1 revenue update come as the stock’s share price return is up 8.9% year to date, while the 1 year total shareholder return is down 6.1%. This suggests improving short term momentum against a softer longer term outcome. If you are...

Recent share performance and business snapshot ONE Gas (OGS) has drawn fresh investor attention after the stock fell about 2.2% in the latest session and is down roughly 7.9% over the past week. The utility now trades near US$76.02, with recent returns showing a decline of about 14.5% over the past month and 12.9% over the past 3 months, while the 1 year total return remains positive at roughly 5.3%. ONE Gas operates a regulated natural gas distribution business serving around 2.3 million...

Why Saia’s New Terminals Matter for Investors Saia (SAIA) recently opened new freight terminals in Marysville, Washington, and Edinburgh, Indiana, expanding its less than truckload network in the Pacific Northwest and Midwest to better align with customer demand. See our latest analysis for Saia. The latest openings come as Saia’s share price has shown strong momentum, with a 1-month share price return of 9.28% and a year-to-date share price return of 43.02%. The 1-year total shareholder...

Ciena (CIEN) is in focus after a run of international deals, including Biznet’s use of WaveLogic 5 Extreme in Indonesia and Cirion Technologies’ new Network as a Service platform in Latin America. See our latest analysis for Ciena. These international deals have arrived during a strong run for the stock, with a 30 day share price return of 6.41% and a 90 day share price return of 71.02%. The 1 year total shareholder return is very large, pointing to powerful momentum that recent announcements...

Recent performance snapshot Sionna Therapeutics (SION) has quietly drawn more investor attention after a series of completed clinical trials across its cystic fibrosis pipeline, with the stock posting gains over the past month and over the past three months. See our latest analysis for Sionna Therapeutics. With the share price at $42.82, Sionna Therapeutics has paired a 9.37% 30 day share price return and 25.61% 90 day share price return with a very large 1 year total shareholder return of...

Wondering whether Luckin Coffee at US$32.52 is offering value or just noise in the headlines? This article breaks down what the current price is really implying. The stock has been relatively quiet over the last year with a 1.2% return, but that sits alongside a 3.9% gain over the past week and a decline of 7.7% over the last month and 8.2% year to date. Recent coverage has focused on Luckin Coffee's position in the Chinese coffee market and the competitive backdrop with both local rivals...

Recent commentary has put LyondellBasell Industries (LYB) in the spotlight as a value stock, with analysts pointing to earnings expectations and improved rankings that appear to be drawing fresh interest from investors. See our latest analysis for LyondellBasell Industries. The stock has cooled off in the short term, with a 1‑month share price return down 10.47% and a 7‑day share price return down 3.70%. Momentum over longer periods remains stronger, with a 90‑day share price return of 15.34%...

How Tsakos Energy Navigation (NYSE:TEN) Has Been Trading Recently With no single headline event driving attention today, Tsakos Energy Navigation (NYSE:TEN) is drawing interest mainly for its recent performance, including a share price of $37.92 and a market value of about $1.13b. See our latest analysis for Tsakos Energy Navigation. Recently, Tsakos Energy Navigation's share price has pulled back, with a 7 day share price return down 11.01% and a 30 day share price return down 10.57%...

eBay stock’s recent performance in context eBay (EBAY) has quietly outperformed many retail-focused stocks recently, with the share price up 6.0% over the past month and 23.1% over the past 3 months. This has drawn fresh attention from investors reviewing online marketplace exposure. See our latest analysis for eBay. Looking beyond the recent rally, eBay’s 1 day share price return of 0.99% and year to date share price return of 26.75% sit alongside a 1 year total shareholder return of 49.96%...

Recent performance snapshot Marten Transport (MRTN) has drawn fresh attention after a strong recent share performance. The stock is up 1.8% in the latest session, about 15.8% over the past month, and 29.8% in the past 3 months. See our latest analysis for Marten Transport. Beyond the recent bounce, the stock shows strong momentum, with a 7 day share price return of 5.2%, a 30 day share price return of 15.8% and a year to date share price return of 53.3%. The 1 year total shareholder return of...

In late May 2026, Hormel Foods reported second-quarter results showing sales of US$2,972.6 million and lower year-on-year earnings, while also reducing its full-year 2026 diluted EPS guidance range to US$1.28–US$1.37 but maintaining expected net sales of US$12.2–US$12.5 billion and operating income of US$0.96–US$1.02 billion, including the loss on the sale of its whole-bird turkey business. Despite the softer profitability outlook, Hormel’s combination of six consecutive quarters of organic...

Why Delek US Holdings Is Back on Investors’ Radar Delek US Holdings (DK) has drawn fresh attention after highlighting progress on its Enterprise Optimization Plan, completing the Big Spring refinery turnaround on schedule and on budget, and continuing the ramp-up of the Delaware basin Libby 2 Plant. See our latest analysis for Delek US Holdings. The recent 3.3% one day share price return and 5.2% 7 day share price return suggest investors are responding to the turnaround progress. A 54.3%...

On May 21, 2026, Vertex Pharmaceuticals announced that Health Canada accepted for review a New Drug Submission for suzetrigine, a first-in-class, non-opioid, non-NSAID oral NaV1.8 inhibitor for moderate-to-severe acute pain in adults, following its earlier U.S. approval as JOURNAVX. This regulatory step, alongside FDA review progress for Vertex’s immunoglobulin A nephropathy candidate povetacicept, highlights the company’s effort to expand beyond cystic fibrosis into broader pain and kidney...

Event driven interest in Hyperliquid Strategies Hyperliquid Strategies (PURR) is drawing fresh attention after an analyst compared its trading setup to past gamma squeeze episodes, pointing to upcoming small cap index inclusion and a relatively small free float. See our latest analysis for Hyperliquid Strategies. The recent spike in speculative interest sits on top of already strong momentum, with 1-day and 7-day share price returns of 16.98% and 30.25%, and a year to date share price return...

Recent performance snapshot Paymentus Holdings (PAY) has drawn investor attention after a period of mixed share performance, with the stock up about 1% over the past day but down around 15% over the past month. Over the past 3 months the stock is lower by roughly 8%, and it is also down around 41% over the past year, while the company reports annual revenue of about US$1.28b and net income of US$74.01m. See our latest analysis for Paymentus Holdings. With the share price at US$23.49, the...

In May 2026, Zoom Communications, Inc. reported first-quarter results showing sales of US$1,239.01 million and net income of US$425.68 million, alongside new revenue guidance for the second quarter and full fiscal year 2027 and an update on its multibillion-dollar share repurchase program. The combination of higher quarterly earnings, stronger per-share profitability, and continued buybacks highlights how Zoom is using its cash generation to support both growth initiatives and capital...

Travere Therapeutics recently received a Notice of Allowance from the USPTO for a patent covering certain methods of using FILSPARI (sparsentan) to treat IgA nephropathy in the US, with protection expected to extend into October 2037 once issued and listed in the FDA’s Orange Book. This added layer of intellectual property protection around FILSPARI’s IgA nephropathy use could strengthen Travere’s competitive moat in rare kidney diseases, even as the product remains subject to strict REMS,...

Keel Infrastructure stock: recent performance snapshot Keel Infrastructure (KEEL) has drawn investor attention after a strong rebound in recent periods, with the stock up 1.1% over the past day, 18.1% over the past week, and 83.8% over the past month. See our latest analysis for Keel Infrastructure. At a share price of $5.68, Keel Infrastructure’s recent 1 month share price return of 83.82% and year to date share price return of 118.46% sit alongside a very large 1 year total shareholder...

Summit Therapeutics (SMMT) is back in focus after reporting positive overall survival data from its Phase III HARMONi-6 trial in advanced squamous NSCLC, along with strong response rates in a Phase II metastatic colorectal cancer study. See our latest analysis for Summit Therapeutics. Those new ivonescimab data arrive after a steady run in the stock, with a 90 day share price return of 16.08% and a very large 3 year total shareholder return, suggesting momentum has been building around...

If you are wondering whether Flowserve stock around its recent US$75.51 close still offers value, the next sections will walk through what the current price might be implying. The stock has delivered returns of 8.5% over the past 7 days, 5.4% over the last 30 days, 6.7% year to date, 54.9% over 1 year, 130.1% over 3 years and 92.4% over 5 years. This naturally raises questions about what is already priced in and how much risk you are taking on at this level. These moves are occurring...